Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elsiglutide for prevention of chemotherapy-induced diarrhea in colorectal cancer
2011-004981-13Phase 2Completed
- Sponsor
- Helsinn
- Start
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diarrhea comparing Elsiglutide with Placebo (2 arms). Primary endpoint: No diarrhea from Day 1 to Day 14. Started Nov 2011; status: completed.
02
Drugs
elsiglutide
03
Conditions
diarrhea
Beyond the preview
Go deeper on 2011-004981-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004981-13.